Gene Panel to Receive Overwhelming Hike in Revenues by 2025 – 2032

Cell Therapy Industry

SkyQuest Technology Group recently introduced Gene Panel Market study with in-depth overview, describing about the Product/Industry Scope and elaborates market outlook and status (2025-2032). The quick development of personalized medicine and genetic technologies. Gene panels are now more reasonably priced due to the decline in the cost of genomic sequencing, which makes comprehensive genetic testing and analysis of a broad variety of illnesses possible. The rising incidence of hereditary diseases and the expanding demand for precise, customized treatment plans are driving this expansion. Additionally, as gene panels offer helpful insights into genetic predispositions and potential treatment options, their growing application in research, diagnostics, and therapeutic development is propelling market expansion.

Gene Panel Market size was valued at USD 2.86 Billion in 2023 and is poised to grow from USD 3.41 Billion in 2024 to USD 14.02 Billion by 2032, growing at a CAGR of 19.30% during the forecast period (2025-2032).

A gene panel is a collection of genes examined collectively to identify genetic variations associated with conditions or disorders. Gene panels are utilized in illness research, personalized medicine, and genetic condition diagnostic testing. They make it possible to effectively and selectively investigate multiple genes at once, shedding light on hereditary illnesses and assisting in the creation of tailored treatment plans. Gene panels have a bright future ahead of them due to continuous advancements in bioinformatics and sequencing technology, which will increase their applicability and precision, facilitate their incorporation into standard clinical practice, and increase their usage in both therapeutic and preventive settings.

Get a Free Sample PDF of the Report – http://www.skyquestt.com/sample-request/gene-panel-market

The 2025 global Gene Panel Market report provides a comprehensive analysis of key industry players, market trends, pricing structures, and competitive dynamics, offering insights into the market landscape from 2025 to 2032. As a rapidly evolving sector, the Gene Panel Market drives economic growth, innovation, and technological advancements through the development, production, and distribution of products and services. This report highlights the market’s growth potential and its impact on global industries, providing valuable insights for stakeholders, investors, and policymakers.

Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The Gene Panel Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.

Global Gene Panel Market is segmented by Product and Services, Technique, Design, Application, End User and Region.

Based on Product and Services, the market is segmented into Test Kits, and Testing Services.
Based on Technique, the market is segmented into Amplicon-based Approach, and Hybridization-based Approach.
Based on Design the market is segmented into Predesigned Gene Panel, and Customized Gene Panel.
Based on Application, the market is segmented into Cancer Risk Assessment, Diagnosis of Congenital Diseases, and Pharmacogenetics.
Based on end user, the market is segmented into Research and Academic Institutes, Hospital and Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies.
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Gene Panel Market – Regional Analysis:

North America dominates the global gene panel market due to its advanced healthcare infrastructure, high investment in biotechnology research, and a strong focus on personalized medicine. Through the allocation of massive funds for genomic research within this region, one can observe that there are strong regulatory structures already in place as well as a high uptake of advanced technologies.

Demand for complex gene panels in the US and Canadian regions is primarily driven by major pharmaceutical and biotechnology firms which have a solid network of hospitals and diagnostic laboratories. Other than that, the gene panel industry continues to grow due to North America’s conducive policy environment and collaboration among researchers thereby fostering innovation.

Top Market Players in Gene Panel Market are:

Qiagen
Roche
Illumina
Thermo Fisher Scientific
Agilent Technologies
Bio-Rad Laboratories
PerkinElmer
Becton, Dickinson and Company (BD)
Sangamo Therapeutics
Genomics England
Personalis, Inc.
Twist Bioscience Corporation
Castle Biosciences, Inc
Neogenomics Laboratories
NantHealth
Macrogen
Myrtelle Inc.
Eurofins Genomics
Guardant Health, Inc.
Myriad Genetic Laboratories Inc.

For a customized report, contact us to request personalization – http://www.skyquestt.com/speak-with-analyst/gene-panel-market

Recent Developments:

In August 2024, in a bid to revolutionize gene panel sequencing through greater accuracy and affordability, Illumina introduced the NovaSeq X series, a groundbreaking platform. The latest technology seeks to fast track both research and clinical usage by increasing throughput and improving sensitivity levels; thus, affirming Illumina’s dominance in genomics.

In July 2024, Thermo Fisher Scientific introduced the Oncomine Precision Assay, a comprehensive gene panel for oncology research. This new panel offers expanded coverage of cancer-related genes, enabling more detailed genomic profiling and supporting the development of targeted cancer therapies, thereby advancing precision medicine.

In June 2024, Qiagen unveiled the QIAseq Immune Repertoire Panel, designed to enhance immune system gene analysis. The purpose of this panel is analyzing immune-related genes in detail that helps to investigate the various types of immune disorders, while also positioning Qiagen as a leading company in the field of immunogenomics through personalized immunotherapy methods.

Take Action Now: Secure Your Gene Panel Market Today – http://www.skyquestt.com/buy-now/gene-panel-market

Forward-Looking Insights

The Gene Panel Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.

About Company:

SkyQuest Technology Consulting is a leading Strategy Consulting and Market Research firm, provides syndicated as well as customized research reports and growth consulting services, trusted by CXOs from Fortune 500 Companies, Start-ups, and MSMEs. The company comprises a team of expert research analysts and consultants, adding more than 1200 market research reports in our database each year. These reports offer in-depth analysis on 40+ industries & sub industries across 25 major countries worldwide, serving global clients across diverse industries. The company specializes in delivering customized intelligence, data-driven insights, and strategic advisory services that enable businesses to stay competitive and make informed decisions in rapidly evolving industries.

Contact Details:

SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]

Skyquest Technology

Skyquest Technology

SkyQuest Technology Group is a global market intelligence, innovation management & commercialization organization that connects innovation to new markets, networks & collaborators for achieving sustainable development goals.